As of 2025-07-12, the EV/EBITDA ratio of Harpoon Therapeutics Inc (HARP) is -18.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HARP's latest enterprise value is 483.51 mil USD. HARP's TTM EBITDA according to its financial statements is -26.68 mil USD. Dividing these 2 quantities gives us the above HARP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 13.3x | 10.7x |
| Forward P/E multiples | 12.3x - 20.5x | 16.4x |
| Fair Price | (14.92) - (16.17) | (16.48) |
| Upside | -164.8% - -170.3% | -171.6% |
| Date | EV/EBITDA |